Corrigendum: A Quantitative Assessment of Factors Affecting the Technological Development and Adoption of Companion Diagnostics.

Luo D.; Smith JA.; Meadows NA.; Schuh A.; Manescu KE.; Bure K.; Davies B.; Horne R.; Kope M.; DiGiusto DL.; Brindley DA.

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Corrigendum: A Quantitative Assessment of Factors Affecting the Technological Development and Adoption of Companion Diagnostics.

Luo D., Smith JA., Meadows NA., Schuh A., Manescu KE., Bure K., Davies B., Horne R., Kope M., DiGiusto DL., Brindley DA.

[This corrects the article on p. 357 in vol. 6, PMID: 26858745.].

Original publication

DOI

10.3389/fgene.2016.00104

Type

Journal article

Journal

Front genet

Publication Date

2016

Volume

Keywords

combinational therapy, commercialization, companion diagnostic, healthcare risk management, healthcare translation, personalized medicine, risk:benefit appraisal, stratified medicine